Related Experiment Videos
Initial evaluation of robotic technology for microsurgical vasovasostomy
Wayne Kuang1, Paul R Shin, Surena Matin
1Glickman Urological Institute, The Cleveland Clinic Foundation, Ohio 44195, USA. kuangw@ccf.org
The Journal of Urology
|December 11, 2003
Summary
Robotic assisted vasovasostomy (RAVV) is feasible, though longer and with more adverse events than microscope assisted vasovasostomy (MAVV). It eliminates tremor and achieves similar patency, suggesting a viable alternative for microsurgery.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Microscope assisted vasovasostomy (MAVV) is technically demanding, requiring specialized microsurgical skills.
- Robotic systems offer potential to overcome challenges like tremor and limited dexterity in microsurgery.
Purpose of the Study:
- To determine the feasibility of robotic assisted vasovasostomy (RAVV).
- To compare performance metrics of RAVV against conventional MAVV.
Main Methods:
- A single surgeon performed 10 vasovasostomies on human vas specimens (5 RAVV, 5 MAVV).
- A modified 1-layer technique with 9-0 suture was used.
- Performance measures and adverse haptic events were recorded; patency was assessed via saline instillation.
Main Results:
- RAVV had longer operating times (84 vs 38 minutes) and more adverse haptic events (2.4 vs 0.0) than MAVV.
- Needle passes were similar (16.8 vs 15.2).
- RAVV eliminated tremor, while MAVV showed minimal to moderate tremor. All anastomoses were patent.
Conclusions:
- Robotic assisted vasovasostomy (RAVV) is feasible in an ex vivo human model.
- Despite increased operative time and adverse events, RAVV's tremor elimination and comparable patency suggest it as a potential alternative to MAVV.